PubMed Health⌕ Search

Biomedical subjects

C Wofsy

Publications and source records attributed to C Wofsy.

At least 37 records · Page 2Linked to original sources

Cross-linking of Fc gamma receptors and surface antibodies. Theory and application.

B lymphocyte responses to the cross-linking of surface Ig (sIg) are known to be inhibited, when IgG is the cross-linking agent, by the concurrent binding of the Fc portion of the IgG to Fc gamma R. We present a mathematical framework for designing and analyzing experiments aimed at uncovering the inhibition mechanism(s). From our model, we calculate concentrations of receptors and ligands in the different cell surface states, at equilibrium or as a function of time. IgG can cross-link surface receptors in three ways, i.e., by bridging two sIg molecules without Fc binding, by bridging two sIg while binding as well to an Fc gamma R, and by binding to an Fc gamma R and only one sIg. We show how the concentrations or fractions of these distinct cross-linked states depend on experimentally manipulable variables, including the concentrations of intact IgG, bivalent and monovalent IgG fragments, and agents that block Fc binding. Then, using simple signal/response relationships, reflecting active and passive mechanisms of Fc-mediated inhibition, we simulate the results of a variety of experiments. In cases where published experimental results are available, we find that the qualitative predictions of our general model are consistent with the data and that comparisons of simulations with available data provide some quantitative information about the parameters governing the cell surface signaling events. In particular, comparison of model predictions with published experiments on the kinetics of IgG-induced inositol trisphosphate production indicate that sIg cross-links form more rapidly than sIg-Fc gamma R "co-cross-links." Further, IgG-sIg bonds stabilize Fc attachments, i.e., the dissociation of IgG from Fc gamma R is slowed significantly when the IgG is also cross-linked to sIg. Predictions of the model suggest other experiments and ways of presenting the data that will help to identify relationships between the molecular signaling events occurring on the cell surface and the various cellular responses.

Animals↗

Quantification of neonatal cerebral ventricular volume by real-time ultrasonography. Derivation and in vitro confirmation of a mathematical model.

The derivation and in vitro confirmation of a method for the calculation of cerebral ventricular volume determined by cranial ultrasonography is described. The derivation depends on use of the cylindrical coordinate method. Confirmation was performed by construction of ultrasound phantoms from latex balloons embedded in a talc/gelatin matrix. Seventeen phantoms of volumes ranging from 10 to 60 mL were measured. The known volume was then compared to the calculated volume by linear regression analysis. The regression analysis indicated a close correlation between the actual volume of the phantoms and the calculated volume with r = 0.96. Various sources of error in the method are discussed. Our results indicate that the cylindrical coordinate mathematical model when applied to cranial ultrasonography images accurately measures cerebral ventricular volumes.

Analysis of Variance↗

Quantification of neonatal cerebral ventricular volume by real-time ultrasonography. In vivo validation of the cylindrical coordinate method.

Posthemorrhagic ventricular dilation is a common clinical problem in preterm infants who have incurred an intraventricular hemorrhage. Presently there are no clinically applicable methods to follow quantitatively the progression of ventricular dilation at bedside. We describe the in vivo validation of a method to measure ventricular volume using bedside real-time cranial ultrasonography. Six infants undergoing either serial lumbar punctures or cerebral ventricular reservoir taps for posthemorrhagic hydrocephalus were studied. The cerebrospinal fluid (CSF) volume removed ranged from 5.5 mL to 30 mL. A strong correlation was found (r2 = 0.84) between the volume of CSF removed by reservoir tap and the change in ventricular volume calculated by the ultrasound method, whereas the correlation between the volume of CSF removed at lumbar puncture and the change in ventricular volume calculated by the ultrasound method was not as strong (r2 = 0.70). Limitations and sources of error in the method are discussed. We conclude that this procedure is accurate and offers a quantitative method to follow longitudinally posthemorrhagic progressive ventricular dilation.

Cerebral Hemorrhage↗

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis.

We report the first randomized prospective comparative study of long-term maintenance ganciclovir (9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine, BW759U, DHPG) therapy for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (AIDS). Eleven retinitis patients who received a 10-day course of ganciclovir induction therapy and then were randomized to receive either immediate daily ganciclovir maintenance therapy or deferred maintenance (eight deferred maintenance, three immediate maintenance) were evaluated for drug efficacy. Median time to retinitis progression was 42 days for the immediate maintenance group compared with 16 days for the deferred maintenance group, (P = 0.07). After crossing over to maintenance therapy, patients in the deferred group had a median time to retinitis progression of 58 days compared to 16 days while not on maintenance therapy (P = 0.13). Only 9% of cultures obtained while patients received maintenance therapy were positive for cytomegalovirus, vs 40% of those obtained off maintenance (P less than 0.001). We can state then that maintenance therapy with ganciclovir delays, but does not halt, progression of cytomegalovirus retinitis and suppresses, but does not eradicate, cytomegalovirus shedding in patients with AIDS.

Acquired Immunodeficiency Syndrome↗

Effect of membrane flow on the capture of receptors by coated pits. Theoretical results.

Coated pits trap cell surface receptors and mediate their internalization. Once internalized, many receptors recycle back to the cell surface. When recycled receptors are inserted into the plasma membrane, they move until they are again trapped in coated pits. The mechanisms for moving receptors from their insertion sites to coated pits are unknown. Unaided diffusion as the transport mechanism is consistent with the observed kinetics of receptor recycling. Another candidate for the transport mechanism is convection. For receptors that recycle to random positions on the cell surface, or to restricted regions about coated pits, we assess the importance of convective flow in the transport of receptors to coated pits. First we consider local flows set up by the formation of coated pits and their transformation into coated vesicles. As coated pits form and round into coated vesicles, surrounding membrane is drawn inward, creating flows directed toward the coated pit centers. We show that unless the lifetime of a coated pit is very short, 10 s or less, such local flows have a negligible effect on the time it takes receptors to reach coated pits. We also show that they are unlikely to be the mechanism that keeps receptors that have reached coated pits trapped within coated pits until they are internalized. Finally we calculate the mean time tau for a diffusing receptor to reach a coated pit in the presence of membrane flow that is constant in magnitude and direction, as may occur on moving cells. We show that for typical membrane flow velocities, tau can be reduced significantly from its value in the absence of flow. For example, a velocity v = 2.8 micron/min cuts the mean transport time in half.

Biophysical Phenomena↗

Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

All patients with the acquired immunodeficiency syndrome treated for their first episode of Pneumocystis carinii pneumonia at San Francisco General Hospital between 1 April 1985 and 15 July 1985 were evaluated for their response to treatment with dapsone (100 mg/day) by mouth for 21 days. Of 44 patients evaluated, 18 were eligible for the study. Of these 18 patients, the conditions of 7 of them worsened or failed to improve during treatment with dapsone and they were considered treatment failures. These patients were changed to standard therapy after 4 to 8 days of dapsone therapy. The remaining 11 patients (61%) improved within 3 to 10 days after dapsone therapy was started. Side effects of dapsone therapy were noted in 6 of 11 patients (of these 11 patients, 5 had a rash, 1 had a rash and abnormal liver enzymes, and 1 had abnormal liver enzymes), but in none of the patients were these side effects severe enough to require the cessation of medication. Based on comparison with historical controls, oral dapsone therapy alone appeared to be less effective than standard therapy or the combination of dapsone plus trimethoprim for P. carinii pneumonia in patients with acquired immunodeficiency syndrome.

Acquired Immunodeficiency Syndrome↗

Stereological analysis of the muscle-tendon junction in the aging mouse.

Transmission of contractile tension from skeletal muscle fibers to connective tissue elements is thought to occur at the muscle-tendon junctions, specialized regions at the extreme ends of the fibers. Previous stereological studies on adult mouse and chicken fibers have shown that, with reference to equal cross-sectional areas of myofibrils, the muscle-tendon junctions of faster fibers have significantly more surface membrane devoted to force transmission than do those of slower fibers (Trotter et al.: Anat. Rec. 213:16-25, 1985a; Trotter et al.: Anat. Rec. 213:26-32,1985b; Trotter and Baca: Anat. Rec. 218:256-266, 1987). In the present study we have analyzed the muscle-tendon junctions of 30-month-old mice, employing techniques for scanning and transmission electron microscopy and for ultrastructural stereology which are identical to those previously used to study the same muscles in 4-month-old mice. Whereas the principal structural features of the muscle-tendon junctions of fibers from adult and aged mice are indistinguishable, stereological analyses of the fiber-tendon interfaces indicate that, in aging animals, the interfacial ratio (the ratio of the surface area of force-transmitting membrane to the cross-sectional area of force-generating myofibrils) is significantly reduced. While the interfacial ratio of fast-twitch fibers of the adult plantaris is about 14.5, the corresponding ratio in aged animals is about ten. In the predominantly slow-twitch fibers of the adult soleus, the interfacial ratio is about ten at the insertion and about 12.7 at the origin, whereas the corresponding ratios in the aged animals are both about ten.(ABSTRACT TRUNCATED AT 250 WORDS)

Aging↗

The effect of co-operativity on the equilibrium binding of symmetric bivalent ligands to antibodies: theoretical results with application to histamine release from basophils.

A theory for the co-operative binding of bivalent ligands to cell surface or solution antibody is presented. The theory treats both negative co-operativity, where the binding of a ligand to one site on an antibody makes it more difficult to bind to the second site, and positive co-operativity, where the binding of a ligand to one site on an antibody makes it easier to bind to the second site. Candidates for bivalent ligands exhibiting negative co-operativity (caused probably by steric hindrance) are certain anti-immunoglobulin antibodies. We show how to calculate the amount of ligand bound, the fraction of antibody in cross-links (i.e. in ligand-antibody aggregates) and the fraction of antibody in any size ligand-antibody aggregate. With sample calculations it is demonstrated that there can be major differences in the binding and cross-linking properties of co-operative and non-co-operative bivalent ligands. We discuss how the theory can be used to analyze experiments where human basophils or rat basophilic leukemia cells are exposed to bivalent ligands that bind co-operatively to immunoglobulin E.

Animals↗

Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

All patients with the acquired immunodeficiency syndrome and a first episode of Pneumocystis carinii pneumonia seen at the San Francisco General Hospital between November 1984 and April 1985 were evaluated for oral treatment with dapsone (100 mg/d) plus trimethoprim (20 mg/kg body weight X d). All 15 patients who met the entry criteria improved clinically and radiographically within 3 to 10 days after starting treatment. Repeat pulmonary function tests and gallium lung scans after 3 weeks of therapy also showed improvement. Although side effects occurred in 14 patients, in only 2 were they severe enough to require stopping therapy. Both of these patients had worsening skin rash, and dapsone-trimethoprim therapy was stopped after 10 days. When compared with trimethoprim-sulfamethoxazole or pentamidine used to treat P. carinii pneumonia in similar patients, oral dapsone-trimethoprim is at least as effective, seems to be better tolerated, and may have a lower frequency of serious side effects.

Acquired Immunodeficiency Syndrome↗

A morphometric analysis of the muscle-tendon junction.

Transmission of the contractile force produced by skeletal muscle fibers from myofilaments to tendon fibers occurs at the muscle-tendon junction. This interface between muscle and tendon is characterized by an amplification of the membrane area across which force is transmitted, with the result that stress at the muscle-tendon interface is less than it would be if the muscle fiber ended without surface folding. The amount of stress reduction is proportional to the degree of surface amplification. Because an understanding of the mechanical properties of the muscle-tendon junction requires a quantitative appreciation of the amplification of interfacial area, and hence the reduction of stress, produced by membrane elaboration at the muscle-tendon junction, we have developed a reliable morphometric approach for quantifying this surface amplification. The approach reported here makes use of point-counting techniques applied to thin sections of murine muscle-tendon junctions, together with a statistical analysis of the data. The results indicate that the load on the cell membrane at the muscle-tendon junction is reduced approximately 1 order of magnitude by membrane amplification, compared to the load calculated to occur if the muscle fiber ended as a right cylinder. In addition, significant differences in the degree of membrane amplification have been detected among the four muscle-tendon junctions analyzed in this study. These results and methods should prove useful in future analyses of normal and abnormal muscle-tendon junctions.

Analysis of Variance↗

Effect of preferential insertion of LDL receptors near coated pits.

Recent experiments suggest that low density lipoprotein (LDL) receptors on human fibroblasts are not inserted into the plasma membrane uniformly, as earlier experiments indicated, but are inserted into specialized regions, called plaques, where coated pits form. If the consequent reduction in the time required for LDL receptors to diffuse to coated pits were significant, this could alter conclusions drawn from previous calculations based on the assumption that LDL receptors are inserted uniformly. In particular, the conclusion could be wrong that diffusion of LDL receptors to coated pits is the rate limiting step in the interaction of cell surface LDL receptors with coated pits. Here we calculate the extent of the reduction in mean travel time of an LDL receptor to a coated pit, as a function of the plaque radius. We find that only if LDL receptor insertion is limited to a very small portion of the plasma membrane near coated pit sites is there a substantial decrease in the average time it would take an LDL receptor to diffuse to a coated pit. In order for preferential insertion of LDL receptors into plaques to cut the mean receptor travel time in half, plaques would have to take up no more than 10% of the cell surface area; to reduce the travel time by a factor of 10, plaques would have to cover only 2% of the cell surface, approximately twice the area covered by coated pits at 37 degrees C.

Animals↗

Diffusion-limited forward rate constants in two dimensions. Application to the trapping of cell surface receptors by coated pits.

A variety of receptors are known to aggregate in specialized cell surface structures called coated pits, prior to being internalized when the coated pits close off. At 37 degrees C on human fibroblasts, as well as on other cell types, a recycling process maintains a constant number of coated pits on the cell surface. In this paper, we explore implications for receptor aggregation and internalization of the two types of recycling models that have been proposed for the maintenance of the coated pit concentration. In one model, coated pits alternate between accessible and inaccessible states at fixed locations on the cell surface, while in the other model, coated pits recycle to random locations on the cell surface. We consider receptors that are randomly inserted in the membrane, move by pure diffusion with diffusion coefficient D, and are instantly and irreversibly trapped when they reach a coated pit boundary (the diffusion limit). For such receptors, we calculate for each of the two models: the mean time tau to reach a coated pit, the forward rate constant k+ for the interaction of a receptor with a coated pit, and the fraction phi of receptors aggregated in coated pits. We show that for the parameters that characterize coated pits on human fibroblasts, the way in which coated pits return to the surface has a negligible effect on the values of tau, k+, and phi for mobile receptors, D greater than or equal to 1.0 X 10(-11) cm2/s, but has a substantial effect for "immobile" receptors, D much less than 1 X 10(-11) cm2/s. We present numerical examples to show that it may be possible to distinguish between these models if one can monitor slowly diffusing receptors (D less than 1 X 10(-11) cm2/s) on cells whose coated pits have relatively short lifetimes (less than or equal to 1 min). Finally, we show that for the low-density lipoprotein (LDL) receptor on human fibroblasts (D = 4.5 X 10(-11) cm2/s), the predicted and observed values of K+ and phi are in close agreement. Therefore, even for slowly diffusing LDL receptor, unaided diffusion as the transport mechanism of receptors to coated pits is consistent with measured rates of LDL internalization.

Coated Pits, Cell-Membrane↗

Analysis of coated pit recycling on human fibroblasts.

The recycling to the cell surface of previously internalized coated pits has been proposed as a likely mechanism for the rapid regeneration of coated pits on human fibroblast surfaces at 37 degrees C (1). We present a general mathematical model of coated pit recycling for the case when the coat cycles as a single unit, and use it to analyze certain time and temperature dependent data obtained by Anderson et al. (1) and Vermeer et al. (2). We show how recycling can account for these data and how this type of data can be used to distinguish between different possible recycling mechanisms. We show that these data are inconsistent with a two compartment model where coat material simply shuttles back and forth between coated pits and short-lived coated vesicles. From these data we estimate for human fibroblasts at 37 degrees C: that the time for a coated pit to be replenished through recycling after it is lost through internalization is greater than 3.5 min; and that at any moment 53% or less of the cell's clathrin that is involved in coated pit recycling is on the cell surface.

Cell Membrane↗

Interactions of low density lipoprotein receptors with coated pits on human fibroblasts: estimate of the forward rate constant and comparison with the diffusion limit.

We present a theoretical study of the interaction of low density lipoprotein (LDL) receptors with coated pits. From published experiments we estimate that the forward rate constant, k+, for the binding of a LDL receptor to a coated pit on a human fibroblast at 37 degrees C is greater than or equal to 3 X 10(-10) cm2/sec, and the mean time an LDL receptor spends on the cell surface before being captured by a coated pit, tc, is less than or equal to 1.8 min. If, when an LDL receptor enters, it remains within the coated pit until the coated pit pinches off to form a coated vesicle, then k+ = 3 X 10(-10) cm2/sec and tc = 1.8 min. We derive expressions for the diffusion limit of k+ and tc when particles (LDL receptors) diffuse in two dimensions until they hit and are absorbed by circular absorbers (coated pits) that have finite lifetimes. The absorbers appear and disappear at equal rates so that their concentration remains constant. We use these expressions to show that a diffusion limit of k+ = 3 X 10(-10) cm2/ sec would be obtained if D, the diffusion coefficient for an LDL receptor on a human fibroblast at 37 degrees C equaled 3.3 X 10(-11) cm2/sec. Because this value is in agreement with the experimentally determined value for D, we conclude that random insertion of LDL receptors into the plasma membrane, followed by pure diffusional motion of LDL receptors on the cell surface until they are irreversibly absorbed in coated pits, is consistent with experiment.

Cell Membrane↗

Theory of equilibrium binding of a bivalent ligand to cell surface antibody: the effect of antibody heterogeneity on cross-linking.

We investigate the equilibrium binding of symmetric bivalent ligands to a heterogeneous population of symmetric bivalent cell surface receptors. The receptors are heterogeneous in their binding affinities (equilibrium binding constants) for the ligand. For any distribution of receptor binding affinities we show how to calculate the total concentration of receptors that are cross-linked by the ligand, i.e., the concentration of cell surface aggregates composed of two or more receptors, as well as the concentration of any given aggregate. We show that certain qualitative properties of cross-linking which hold for homogeneous antibody populations fail to hold in the heterogeneous case. We use our results to interpret certain in vitro experiments in which synthetic bivalent haptens are used to trigger histamine release from basophils which have on their surface antibody specific for the hapten.

Animals↗